Back to Cardiology
Cardiologyv2001Evidence-Based

CHADS₂ Score for Atrial Fibrillation Stroke Risk

Clinical prediction tool that estimates annual stroke risk in patients with atrial fibrillation. Helps determine whether anticoagulation therapy is warranted based on patient's risk profile for thromboembolic events. Developed from the National Registry of Atrial Fibrillation and validated in multiple populations.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
chads2 assessment
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The CHADS₂ Score for Atrial Fibrillation Stroke Risk is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

CHADS₂ Score = Congestive heart failure (1) + Hypertension (1) + Age ≥75 years (1) + Diabetes mellitus (1) + Stroke/TIA/thromboembolism history (2). Total range: 0-6 points.

Clinical Pearls & Practice Notes

  • CHADS₂ acronym: C-Congestive heart failure, H-Hypertension, A-Age ≥75, D-Diabetes, S₂-Stroke/TIA/thromboembolism (2 points)
  • Developed from National Registry of Atrial Fibrillation in 2001
  • Score 0: 1.9% annual stroke risk - consider CHA₂DS₂-VASc for further stratification
  • Score 1: 2.8% annual stroke risk - intermediate risk category
  • Score 2: 4.0% annual stroke risk - generally recommend anticoagulation
  • Score ≥3: 5.9-18.2% annual stroke risk - strong anticoagulation recommendation
  • C-statistic approximately 0.68 for stroke prediction
  • Validated in multiple populations and healthcare systems
  • Largely superseded by CHA₂DS₂-VASc score for more comprehensive risk assessment
  • Better at identifying high-risk patients than truly low-risk patients
  • Among patients 65-95 years, <7% classified as low risk
  • Does not capture all stroke risk factors (vascular disease, gender, age 65-74)
  • Simple bedside calculation makes it clinically practical
  • Used for anticoagulation decision-making in atrial fibrillation
  • Score ≥2 generally indicates anticoagulation benefit outweighs bleeding risk
  • Consider bleeding risk assessment (HAS-BLED) alongside stroke risk

Evidence & Literature Citations

  1. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864-70.
  2. Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation. 2004;110(16):2287-92.
  3. Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, Selmer C, Ahlehoff O, Olsen AM, Gislason GH, Torp-Pedersen C. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342:d124.
  4. Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GY, Manning WJ; American College of Chest Physicians. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):546S-592S.

Score Interpretation Ranges

Low Risk0 – 0 pts

Low annual stroke risk

Low-Intermediate Risk1 – 1 pts

Low-intermediate annual stroke risk

Intermediate Risk2 – 2 pts

Intermediate annual stroke risk

High Risk3 – 3 pts

High annual stroke risk

High Risk4 – 4 pts

High annual stroke risk

Very High Risk5 – 5 pts

Very high annual stroke risk

Very High Risk6 – 6 pts

Very high annual stroke risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.